Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK

J Biol Chem. 2005 Jun 3;280(22):21237-45. doi: 10.1074/jbc.M413842200. Epub 2005 Mar 14.

Abstract

Clostridium difficile toxin A induces acute colitis with neutrophil infiltration and up-regulation of numerous pro-inflammatory mediators, but the contribution of cyclooxygenase-2 (COX-2) induction in this infection is unknown. We report here that toxin A induces expression of COX-2 and secretion of prostaglandin E2 (PGE2) in a dose- and time-dependent manner in cultured NCM460 human colonocytes and in human intestinal xenografts. This induction was blocked by SB203580, a p38 MAPK inhibitor, which also decreased the phosphorylation of MSK-1, CREB/ATF-1, and COX-2 promoter activity following toxin A stimulation. Gel shift assays indicated that CREB/ATF-1 was the major proteins binding to the COX-2-CRE. Moreover, colonocytes exposed to toxin A produced reactive oxygen species (ROS), which activated p38 MAPK, MSK-1, and CREB/ATF-1, leading to subsequent COX-2 induction and PGE2 secretion. In intact mice, blockage of p38 MAPK inhibited toxin A-mediated induction of COX-2 in enterocytes as well as lamina propria cells, and significantly blocked the toxin A-induced ileal secretion of fluid and PGE2. Furthermore, a selective COX-2 inhibitor also diminished toxin A-associated ileal fluid and PGE2 secretion. The main signaling pathway for toxin A induction of human COX-2 involves ROS-mediated activation of p38 MAPK, MSK-1, CREB, and ATF-1. Toxin A triggers ileal inflammation and secretion of fluid via COX-2 induction and release of PGE2.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bacterial Toxins / pharmacology*
  • Cell Line
  • Colon / cytology*
  • Colon / metabolism
  • Cyclic AMP / metabolism
  • Cyclooxygenase 2
  • Dinoprostone / metabolism*
  • Dose-Response Relationship, Drug
  • Electrophoresis, Polyacrylamide Gel
  • Enterotoxins / pharmacology*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Ileum / metabolism
  • Imidazoles / pharmacology
  • Immunohistochemistry
  • Inflammation
  • Intramolecular Oxidoreductases / metabolism
  • Luciferases / metabolism
  • Membrane Proteins
  • Mice
  • Mice, SCID
  • Models, Biological
  • Nitrobenzenes / pharmacology
  • Phosphorylation
  • Prostaglandin-E Synthases
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Protein Binding
  • Pyridines / pharmacology
  • RNA / metabolism
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Sulfonamides / pharmacology
  • Time Factors
  • Tissue Transplantation
  • Transfection
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Bacterial Toxins
  • Enterotoxins
  • Enzyme Inhibitors
  • Imidazoles
  • Membrane Proteins
  • Nitrobenzenes
  • Pyridines
  • RNA, Messenger
  • Reactive Oxygen Species
  • Sulfonamides
  • tcdA protein, Clostridium difficile
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • RNA
  • Cyclic AMP
  • Luciferases
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • p38 Mitogen-Activated Protein Kinases
  • Intramolecular Oxidoreductases
  • Prostaglandin-E Synthases
  • Dinoprostone
  • SB 203580